Relationship between postmenopausal hormone replacement therapy and ovarian cancer.

[1]  C. la Vecchia,et al.  Menopause, hormone replacement therapy and cancer. , 2001, Maturitas.

[2]  M. Thun,et al.  Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. , 2001, JAMA.

[3]  E. Negri,et al.  Physical activity and risk of ovarian cancer: an Italian case-control study. , 2001 .

[4]  S. Coughlin,et al.  A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. , 2000, Journal of clinical epidemiology.

[5]  R. Hoover,et al.  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000, JAMA.

[6]  V. Beral,et al.  Hormonal therapy for menopause and ovarian cancer in a collaborative re‐analysis of European studies , 1999, International journal of cancer.

[7]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[8]  M. Piver,et al.  Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. , 1997, Obstetrics and gynecology.

[9]  H. Risch.  Estrogen replacement therapy and risk of epithelial ovarian cancer. , 1996, Gynecologic oncology.

[10]  V. Beral,et al.  Risk factors for ovarian cancer: a case-control study. , 1989, British Journal of Cancer.

[11]  P. Wingo,et al.  Estrogen Therapy and the Risk of Breast, Ovarian, and Endometrial Cancer , 1986 .

[12]  N. Day,et al.  The epidemiology of ovarian cancer in Greece: a case-control study. , 1984, European journal of cancer & clinical oncology.

[13]  D. Cramer,et al.  Determinants of ovarian cancer risk. I. Reproductive experiences and family history. , 1983, Journal of the National Cancer Institute.